✦ LIBER ✦

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

✍ Scribed by T. J. de Villiers; A. A. Chines; S. Palacios; P. Lips; A. Z. Sawicki; A. B. Levine; C. Codreanu; N. Kelepouris; J. P. Brown

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 269 KB
Volume: 22
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-010-1302-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained efficacy and safety of bazedox

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

✍ S. L. Silverman; A. A. Chines; D. L. Kendler; A. W. C. Kung; C. S. Teglbjærg; D. 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 570 KB

Effect of raloxifene on bone mineral den

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

✍ H. Morii; Y. Ohashi; Y. Taketani; M. Fukunaga; T. Nakamura; A. Itabashi; S. Sark 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

Comparison of nonrandomized trials with

Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis

✍ Dr. Charles Y.C. Pak; Khashayar Sakhaee; Norman H. Bell; Angelo Licata; Conrad J 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 786 KB

The results of slow-release sodium fluoride (SR-NaF) treatment in two nonrandomized trials involving 65 patients with postmenopausal osteoporosis from the primary site and 121 patients from collaborative sites were compared with those obtained from 54 treated patients and 56 patients taking placebo

Effects of long-term strontium ranelate

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

✍ Jean-Yves Reginster; Dieter Felsenberg; Steven Boonen; Adolfo Diez-Perez; Rene R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of infliximab in pat

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)

✍ Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeW 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views